Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?

Nachega JB ; Rosenkranz B ; Pham PA (2011)

Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za

Gesondheidswetenskappe

Farmakologie

Journal Articles (NON-subsidised)

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/45055
This item appears in the following collections: